Scarica l'app Stockscreener
3.67
3.09%
0.11
Dopo l'orario di chiusura:
3.64
-0.03
-0.82%
Precedente Chiudi:
$3.56
Aprire:
$3.56
Volume 24 ore:
1.16M
Relative Volume:
0.54
Capitalizzazione di mercato:
$361.06M
Reddito:
$361.07M
Utile/perdita netta:
$-71.54M
Rapporto P/E:
-4.6456
EPS:
-0.79
Flusso di cassa netto:
$-47.97M
1 W Prestazione:
+0.82%
1M Prestazione:
+23.99%
6M Prestazione:
+50.41%
1 anno Prestazione:
+1,151%
Intervallo 1D:
$3.41
$3.68
Intervallo di 1 settimana:
$3.41
$3.745
Portata 52W:
$0.2519
$4.88
Oncology Institute Inc Stock (TOI) Company Profile
Nome
Oncology Institute Inc
Settore
Industria
Telefono
562-735-3226
Indirizzo
18000 STUDEBAKER RD, CERRITOS
Confronta TOI con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TOI
Oncology Institute Inc
|
3.67 | 350.24M | 361.07M | -71.54M | -47.97M | -0.79 |
|
HCA
Hca Healthcare Inc
|
470.39 | 106.53B | 74.37B | 7.31B | 8.10B | 25.88 |
|
THC
Tenet Healthcare Corp
|
199.45 | 17.46B | 20.69B | 2.40B | 1.55B | 15.62 |
|
UHS
Universal Health Services Inc
|
219.88 | 13.62B | 16.08B | 1.20B | 1.06B | 17.82 |
|
FMS
Fresenius Medical Care Ag Adr
|
23.51 | 13.81B | 21.23B | 924.30M | 2.22B | 1.2272 |
|
EHC
Encompass Health Corp
|
106.37 | 10.68B | 5.51B | 494.70M | 386.40M | 4.84 |
Oncology Institute Inc Stock (TOI) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-11-25 | Iniziato | Needham | Buy |
| 2025-07-23 | Iniziato | Noble Capital Markets | Outperform |
| 2025-07-16 | Iniziato | B. Riley Securities | Buy |
| 2025-05-15 | Iniziato | BTIG Research | Buy |
| 2024-02-26 | Ripresa | Jefferies | Buy |
| 2022-09-14 | Iniziato | Guggenheim | Buy |
| 2022-08-15 | Iniziato | Jefferies | Buy |
Mostra tutto
Oncology Institute Inc Borsa (TOI) Ultime notizie
Can The Oncology Institute Inc. Equity Warrant stock sustain free cash flow growth2025 Dividend Review & Technical Entry and Exit Tips - Улправда
Will The Oncology Institute Inc. Equity Warrant stock reach Wall Street targetsJuly 2025 Recap & Expert Approved Trade Ideas - Улправда
Will The Oncology Institute Inc. stock gain from government policiesMarket Growth Report & Momentum Based Trading Signals - Улправда
Is The Oncology Institute Inc. Equity Warrant stock a top pick in earnings seasonJuly 2025 Action & Low Risk Profit Maximizing Plans - Улправда
How institutional buying supports The Oncology Institute Inc. stockEarnings Trend Report & Weekly Momentum Stock Picks - Bölüm Sonu Canavarı
How The Oncology Institute Inc. Equity Warrant stock reacts to oil pricesPortfolio Growth Summary & Weekly Market Pulse Updates - Улправда
Take Profit: Will The Oncology Institute Inc. Equity Warrant stock benefit from infrastructure spending2025 Price Action Summary & Technical Pattern Alert System - ulpravda.ru
The Caris Precision Oncology Alliance Welcomes Providence Swedish Cancer Institute - Sahm
Will The Oncology Institute Inc. stock gain from strong economyJuly 2025 Pullbacks & Smart Allocation Stock Reports - DonanımHaber
Is The Oncology Institute Inc. stock a buy before product launchesQuarterly Market Review & Weekly High Return Opportunities - DonanımHaber
How The Oncology Institute Inc. Equity Warrant stock performs in stagflationShare Buyback & Fast Gain Swing Trade Alerts - DonanımHaber
Update Recap: How The Oncology Institute Inc. Equity Warrant stock reacts to oil pricesJuly 2025 Intraday Action & Consistent Profit Focused Trading Strategies - Улправда
Will The Oncology Institute Inc. Equity Warrant stock keep outperforming rivalsMarket Performance Report & Daily Technical Forecast Reports - DonanımHaber
The Oncology Institute: Making Progress (NASDAQ:TOI) - Seeking Alpha
Is The Oncology Institute Inc. stock supported by strong fundamentals2025 Pullback Review & Community Consensus Trade Signals - Улправда
Brad Hively Sells 13,333 Shares of Oncology Institute (NASDAQ:TOI) Stock - MarketBeat
Oncology Institute Director Sells Shares to Cover Tax Liabilities - TradingView — Track All Markets
Officer/Dir Hively Surrenders 13,333 Of Oncology Institute Inc [TOI] - TradingView — Track All Markets
TOI (NASDAQ: TOI) notice covers planned Rule 144 sale of 13,333 shares - Stock Titan
MSN Money - MSN
Wall Street analysts’ outlook for Oncology Institute Inc (TOI) - setenews.com
Can The Oncology Institute Inc. Equity Warrant stock deliver strong Q4 earnings2025 Short Interest & Growth Focused Entry Point Reports - Newser
How The Oncology Institute Inc. Equity Warrant stock compares to market leadersMarket Sentiment Report & Weekly Sector Rotation Insights - Newser
TOIIW SEC FilingsThe Oncology Institute Inc 10-K, 10-Q, 8-K Forms - Stock Titan
This trade activity should not be overlooked: Oncology Institute Inc (TOI) - setenews.com
The Caris Precision Oncology Alliance Welcomes UAMS Winthrop P. Rockefeller Cancer Institute - Yahoo Finance
Why The Oncology Institute Inc. Equity Warrant stock could benefit from AI revolutionPortfolio Profit Report & AI Based Buy/Sell Signal Reports - Newser
Is The Oncology Institute Inc. Equity Warrant stock a safe investment in uncertain marketsQuarterly Performance Summary & High Accuracy Swing Entry Alerts - Newser
Oncology Institute Announces Board Member Resignation - TipRanks
Oncology Institute Announces Board Resignation - TradingView
Oncology Institute director Gabe Ling resigns - TipRanks
The Oncology Institute Announces Resignation of Board Member Gabe Ling - The Manila Times
The Oncology Institute announces resignation of board member Gabe Ling - marketscreener.com
Oncology Institute (NASDAQ: TOI) starts search to replace Gabe Ling on board - Stock Titan
What analysts say about The Oncology Institute Inc stockPrice Volatility Patterns & Build a Dividend-Powered Portfolio - earlytimes.in
The Oncology Institute (TOI) Loses 20% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - MSN
US Stocks Recap: Will The Oncology Institute Inc. Equity Warrant stock split again soonWeekly Market Report & Free Real-Time Market Sentiment Alerts - moha.gov.vn
Needham & Company LLC Initiates Coverage on Oncology Institute (NASDAQ:TOI) - Defense World
The Oncology Institute Reports Second Quarter 2025 Financial Results and Reaffirms Full Year 2025 Guidance - ADVFN
Oncology Institute Projects Strong 2025 Revenue Growth - MSN
The Oncology Institute Reports First Quarter 2025 Financial Results and Reaffirms Full Year 2025 Guidance - ADVFN
Oncology Institute initiated with a Buy at Needham - MSN
There is no doubt that Oncology Institute Inc (TOI) ticks all the boxes. - Setenews
Needham Initiates Coverage on Oncology Institute With Buy Rating, $5 Price Target - MarketScreener
Oncology Institute (TOI) Gains "Buy" Rating with $5 Price Target by Needham | TOI Stock News - GuruFocus
Needham Initiates Coverage of Oncology Institute (TOI) with Buy Recommendation - Nasdaq
[Form 4] Oncology Institute, Inc. Insider Trading Activity - Stock Titan
Investors Give The Oncology Institute, Inc. (NASDAQ:TOI) Shares A 29% Hiding - simplywall.st
A Mysterious Stock Has Rallied Over 950% This Year. Here's 1 Key Reason Why Investors Are Turning Bullish - The Motley Fool
Oncology Institute Inc Azioni (TOI) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.19%
0.95%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):